//=time() ?>
Happy to report our study on #RAS mutations/amplification in metastatic #ColonCancer. KRAS amplification likely confers resistance to anti-EGFR therapy. An excellent collaboration between @UPMCnews @MDAndersonNews @HenryFordNews #PrecisionMedicine #GIPath https://t.co/5UztaMBBOT